HKG:6821 Market Cap

HKG:6821 has a market cap or net worth of 32.31 billion as of June 27, 2025. Its market cap has increased by 13.71% in one year.

Market Cap

32.31B

Enterprise Value

24.11B

Revenue

6.38B

Ranking

n/a

PE Ratio

30.33

Stock Price

74.40

Market Cap Chart

Since November 18, 2016, HKG:6821's market cap has increased from 5.59B to 32.31B, an increase of 477.86%. That is a compound annual growth rate of 22.59%.

Market Cap History

Date	Market Cap	% Change
Jun 27, 2025	32.31B	15.70%
Dec 31, 2024	27.92B	-38.76%
Dec 29, 2023	45.59B	-23.48%
Dec 30, 2022	59.58B	-56.36%
Dec 31, 2021	136.53B	58.47%
Dec 31, 2020	86.15B	157.03%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BeOne Medicines	237.03B
Hansoh Pharmaceutical Group Company	173.02B
JD Health International	135.68B
Innovent Biologics	129.81B
WuXi Biologics	101.72B
Sino Biopharmaceutical	92.46B
CSPC Pharmaceutical Group	89.38B
Akeso	83.03B

Market Cap Rankings